A kind of nanoparticle and its preparation method and application

A nanoparticle and carboxyl technology, applied in the field of medicine, can solve the problems of limited treatment and increase tumor resistance, and achieve the effect of high biological safety, reducing drug resistance and good targeting.

Active Publication Date: 2022-02-18
SHANDONG UNIV QILU HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Accumulating evidence suggests that the genetic and epigenetic heterogeneity of GBM may underlie the current treatment limitations
Due to the existence of the blood-brain barrier (BBB), serious side effects and other factors, the strategy of single chemotherapy drugs in the treatment of glioma cannot achieve good clinical results, and even increase the drug resistance of tumors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of nanoparticle and its preparation method and application
  • A kind of nanoparticle and its preparation method and application
  • A kind of nanoparticle and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] Example 1 Preparation of si-GPX4@IONPs nanoparticles

[0103] In the first step, 1 mL of carboxyl-containing porous IONPs (10 mg / mL) was added to an aqueous solution of diethylpyrocarbonate (DEPC) at pH = 6, followed by 9.6 mg of EDC and 5.8 mg of NHS, and stirred at room temperature for 1 h. In the second step, before loading si-GPX4, the 5' end of the sense strand of si-GPX4 was modified with amino group and labeled with 5-carboxyfluorescein (FAM). si-GPX4 with different I / S ratios was added to the solution obtained in the first step for 30 min to obtain si-GPX4@IONPs, and the binding force was evaluated by agarose gel electrophoresis.

Embodiment 2

[0104] Example 2 Preparation of Pt+si-GPX4@IONPs nanoparticles

[0105] Operate under dark conditions, mix 10mg / mL si-GPX4@IONPs with 3mg / mL Pt and stir for 8 hours to make the two fully electrostatically adsorbed. The mixture was centrifuged at 1000 rpm with an ultrafiltration centrifuge tube (MWCO: 10kD) to remove free Pt to obtain Pt+si-GPX4@IONPs. The encapsulation efficiency and drug loading were detected by inductively coupled plasma mass spectrometry (ICP-MS).

Embodiment 3

[0106] Example 3 Preparation of FA / Pt+si-GPX4@IONPs nanoparticles

[0107] Operated under dark conditions, liposomes and DEPC H of 1mg / mL Pt+si-GPX4@IONP 2 o 2 The solutions were mixed and hydrated to obtain FA / Pt+si-GPX4@IONPs. The final solution was filtered through a 200nm polycarbonate membrane and purified by a Sephadex G-100 column, condensed and stored at 4°C for further use;

[0108] Among them, the liposome is composed of lipofectamine 2000 and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate (polyethylene glycol) 2000] (DSPE-PEG2k-FA) (molar ratio 6:1).

[0109] Among them, the preparation process of si-GPX4@IONPs, Pt+si-GPX4@IONPs, FA / Pt+si-GPX4@IONPs nanoparticles is as follows: figure 1 Shown; SEM and TEM images of IONPs, si-GPX4@IONPs, Pt+si-GPX4@IONPs nanoparticles figure 2 Shown; TEM image of FA / Pt+si-GPX4@IONPs nanoparticles image 3 Shown; The particle size distribution of IONPs, Pt+si-GPX4@IONPs, FA / Pt+si-GPX4@IONPs nanoparticles is as fol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

The present invention belongs to the technical field of medicine, and specifically relates to a Pt+si-GPX4@IONPs, FA / Pt+si-GPX4@IONPs nanoparticle and its preparation method and application. In the present invention, cisplatin, si-GPX4 and IONPs are combined The combination of two therapeutic drugs can induce glioma cell death from two aspects of apoptosis and ferroptosis, and FA-modified liposomes are used to encapsulate three drugs, cisplatin, si‑GPX4 and IONPs, which are targeted Well, with the advantages of high biocompatibility, it has achieved a good therapeutic effect on glioma, solved the shortcomings of traditional single chemotherapy drugs, and proposed a multi-target combined chemotherapy method for glioma cells.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to a Pt+si-GPX4@IONPs nanoparticle, a FA / Pt+si-GPX4@IONPs nanoparticle and a preparation method and application thereof. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Glioma is considered one of the deadliest and most difficult to treat cancers. Glioma can be divided into 4 grades according to the degree of malignancy (WHO I, II, III and VI), and the most common glioma is type IV glioma, also known as glioblastoma (GBM). The current comprehensive treatment including surgical resection, chemotherapy and radiotherapy has limited curative effect on GBM patients, and the median s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K47/24A61K47/22A61K33/243A61K33/26A61P35/00A61K31/7105
CPCA61K9/5146A61K33/243A61K33/26A61K31/7105A61P35/00
Inventor 倪石磊张玉霖王军鹏
Owner SHANDONG UNIV QILU HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap